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1050-l 00 Prediction of Major Coronary Events in Stable Angina: 
The IONA Study 
Alex D. McMahon, Henry J. Dargie, Ian Ford, Stewart HiIlls, Kim M. Fox, University of 
Glasgow, Glasgow, United Kingdom, Royal Brompton Hospital. London, United Kingdom 
Background: The Impact Of Nicorandil in Angina study (ION) was a randomized con- 
trolled trial in 5126 patients with stable angina. Nicorandil, a potassium channel activator, 
reduced the incidence of the primary end point (CHD death, non fatal Ml or unplanned 
hospitalization for anglna) by 17% HR 0.83 (0.72, 0.97), p = 0.014 and is the first anti 
angina1 agent to be shown to improve clinical outcome in stableangina. 
Methods: We interrogated the IONA database to identify factors related to outcome in 
order to inform clinical decision making about prognosis. Candidate factors were age. 
gender, Canadian Cardiovascular Society Functional status (CCSF). smoking, systolic 
blood pressure (SBP). heart rate, body mass index and histories of myocardial infarction, 
coronary artery bypass graftrng (CABG), hypertension, diabetes, left ventricular hypertro- 
phy on EKG and left ventricular systolic dysfunction. These were entered Into a Cox pro- 
portional hazards model 
Results: All risk factors with the exception of gender, SBP, CABG, diabetes and hyper- 
tension were univariate predictors of the primary end point. The strongest multivariate 
predictors of outcome were, in descending order of Importance. CCSF score IV, HR 5.49 
(3.10, lO.OO), p < 0.001; CCSF score Ill, HR 2.13 (1.67, 2.7+), p < 0.001; CCSF II, HR 
1.25 (1.04, 1.51). p = 0.021; previous MI, HR 1.54 (1.30, 1.83), p < 0.001; current smok- 
ing,HR1.32(1.10,1.60),p=0.004;age,HR1.05(1.00, l.ll),p=O.O35;treatmentwith 
nicorandil, HR 0.82 (0.71, 0.95), p = 0.009. 
Conclusions: In the presence of medication which reduces major coronary events the 
profile of risk factors in patrents with stable anglna changes considerably. Traditionally 
strong factors including previous CABG, male gender, hypertension and diabetes were 
no longer even univanately predictive of outcome. By far the strongest predictor was clin- 
ical severity of angina (CCSF score) while smoking and previous Ml also remain Inde- 
pendently though less predictive than symptoms. These data could have an important 
influence on clinical assignment of nsk and therefore on future clinical practice. 
1050-101 Cumulative Infectious Burden (but Not Any Single Past 
Infection) Is Interrelated With Traditional Risk Factors to 
Cause Coronary Artery Disease 
Einat Cotter-Metzkor. Ricardo Krakover. Gad Cotter Miriam Ben-Yaakov, Tzllia 
Lazarovich, Zehava ChewLevy, Ronit Zaidenstein,hlomo Fytlovich, Ida Boldur. Ahuva 
Golik, Assaf-Harofeh Medical Center, Zerifin, Israel 
The causative role of past infections in the pathogenesis of coronary artery disease 
(CAD) is uncertain. 
Methods: We evaluated 179 consecutive patients, admitted electively for coronary 
angiography, for traditional atherosclerotic risk factors, serologic markers for prior infec- 
tions with Chlamydia pneumonia, Hellcobacter pylori, Cytomegalovirus (CMV). Epstew 
Barr virus (EBV), Mycoplasma pneumonia, Hepatltls A virus (HAV), Hepatitis B virus 
(HBV). Hepatitis C virus (HCV), fibrinogen and ferritin. Patients underwent coronary 
angiography. Patients with CAD were compared to patients with angiograpicaly normal 
coronary arteries (NCA). 
Results: Serologic markers of past infection with Chlamydia pneumonia (IgG, IgA) and 
serologic marker of past infection with Helicobacter pylorl (IgG) were more prevalent in 
the CAD patients group compared to NCA patients. However, after adjustment for tradi- 
tlonal risk factors none of the serologic markers for infectious agents remained an inde- 
pendent risk factor for CAD, while the cumulative effect of numerous past infections was 
found to progressively increase the risk for CAD. Having 3-4 positive serologic markers 
confers a risk for CAD of 7.5 (Cl 1.4-39.1) compared having O-2 serologic markers. Hav- 
ing more than 5 serologic markers was shown to confer an even greater nsk for CAD 
(16.8; Cl 2.8-99). 
Conclusions: The cumulative infections burden rather than any specific infection is 
related to an increased risk of coronary artery disease, implying that increased inflamma- 
tory burden over long periods of time might contribute to the pathogenesis of ischemic 
heart disease. 
1050-l 02 Relation of Testosterone With Inflammatory Cytokines 
in Men With Coronary Artery Disease 
Peter J. Puqh Chris J. Malkin, Paul D. Morns, Joanne Nettleship, Richard D. Jones, T. 
H. Jones, Kevin S. Charmer, Royal Hallamshire Hospital, Sheffield, United Kingdom, 
University of Shefheld Medrcal School, Sheffield, Umted Kingdom 
Background: Various cytokines have been identified as mediating the inflammatory pro- 
cess of atherosclerosis. Testosterone is known to possess anti-inflammatory properties 
and has been suggested as a therapy for some inflammatory conditions. Men with coro- 
nary artery disease have reduced levels of testosterone. Animal studies suggest that 
androgens may retard the progresslon of atherosclerosis. The mechanism of benefit is 
unknown but could involve immune modulation. In this study, we examined the relation 
between circulating levels of testosterone and inflammatory cytokines in men with estab- 
lished coronary artery disease. 
Methods: Seventy five men with angiographically proven coronary artery disease (z 
70% stenosis in 2 1 coronary artery) were studied. Blood samples were taken between 8 
and 9.30am. Serum was removed by centrifugation and stored at -80” C until assayed. 
Serum levels of total and bio-available testosterone were measured, together with the 
pro-inflammatory cytokines tumour necrosis factor-a (TNF), interleukin- (II-) lp and 11-6, 
and the anti-inflammatory cytokine II-IO. Compansons were made between eugonadal 
men and those with total testosterone level 5 7.5nmollL or bio-available testosterone 5 
2 5nmol/L, using the Mann Whitney U test. 
Results: Eighteen subjects had low androgen levels. Compared with eugonadal sub- 
jects, levels of II-1p were significantly elevated (516 + 127fg/ml v 253 -t 42fg/ml, 
p=O.O30). Levels of TNF, II-6 and II-10 did not differ significantly between groups (TNF 
2.59 * 0.75pglml ~2.35 + 0.34pg/ml, p=O.785; II-6 3.58 * 0.6lpg/ml ~6.66 f 2.72pg/ml. 
p=O.l90; II-IO 2.42 * l.O4pg/ml Y 1.68 r O.lSpg/ml, p=O.613). There was a significant 
inverse relationship of both total and bio-available testosterone with II-lp (rs-0.262, 
p=O.O24; re-0.283, p=O.O15), but not with other cylokines. 
Conclusion: In men with coronary artery disease, low testosterone levels are associated 
with pro-inflammatory cytokine activation. Whether this represents cause or effect is 
unclear but the data may support a rationale for androgen replacement therapy in men 
with coronary artery disease. 
1050-l 03 Prevalence of Hypogonadism in Men With Coronary 
Artery Disease 
Peter J. Push, Chris J. Malkln, Paul D. Morris, Sonia Asif. Richard D. Jones, T. H. Jones, 
Kevin S. Charmer, Royal Hallamshlre Hospital, Sheffield, United Kingdom, University of 
Sheffield Me&al School, Sheffield, United Kingdom 
Background: Low serum testosterone level has been associated with numerous nsk 
factors for coronary artery disease (CAD) and men with CAD have lower androgan levels 
than controls. Testosterone administration has a beneficial effect on various coronary 
risk factors and has been shown to reduce symptoms and ischaemia in men with angina, 
with greatest effect in hypogonadal men. Men with CAD therefore represent a population 
prone to testosterone deficiency who may especially benefit from hormone treatment. 
The purpose of this study was to determine the size of the problem. Methods: Blood 
samples were taken between 0800 and 0930hours from 900 men with proven CAD (t 
70% stenosis in t 1 epicardIaI coronary artery). 69 subjects with evidence of inflamma- 
tion or elevated C-reactive protein were excluded. Serum levels of total (TT) and bio- 
available testosterone (BT) were measured in the remaining 831. Hypogonadism was 
defined as n < 7.5nmoWL and I or BT 5 2.5nmolIL. Results: TT was low In 117 subjects 
(14.1%). BT was low I” 165 (19.9%). 194 had low TT and / or BT. The prevalence of 
hypogonadism therefore was 23.4%. It was more frequent In the obese (BMl>30) (33.3% 
v 19.1% x 2=15.8. pcO.0001) and less frequent in smokers (13.8% ~24.7% x ‘=5.5, 
~~0.02). There was a significant relationship of hypogonadism with age (figure). 
Conclusion: Using strict criteria, nearly a quarter of men with significant CAD are hypog- 
onadal. Further trials are required to determine the benefits and safety of hormone 
replacement in these patients. 
1050-104 Which Features of the Metabolic Syndrome Predict the 
Presence of Angiographic Coronary Artery Disease? 
Sandra P. Reyna, Joseph 8. Muhlestein, John F. Carlquist, Dale G. Renlund, Donald L. 
Lappb, Tami L. Bair, Robert R. Pearson, Benjamin D. Home, Chloe A. Allen Maycosk, 
Stephanie V. Moore, Jeffrey L. Anderson, LDS Hospital, Salt Lake City, UT, University of 
Utah, Salt Lake City, UT 
Background: The metabolic syndrome (MS), a cluster of vascular risk factors, is growing 
in prevalence. The Adult Treatment Panel Ill Guidelines provide a uniform clinlcal defini- 
tion of MS but offer no information about the individual and combined predictive value 
(PV) of its components for CAD. 
Methods: We tested the PV of the MS and its components for CAD in a consecutive 
series of consenting, prospectwely entered subjects undergoing coronary angiography 
for suspected cardiac disease. Acute Ml at presentation was excluded. Components of 
the MS were assessed at the time of study entry (angiography) and included: 1) fasting 
glucose (FG) 2110 mg/dL, 2) triglyceride (TG) 2150 mg/dL, 3) high density lipoprotein 
cholesterol (HDL) ~40 mg/dL in men or ~50 mg/dL in women. and 4) systolic blood pres- 
sure (SBP) 2130 and/or diastolic (D) BP 285 mmHg. MS was defined as 23 features. 
Waist circumference was not captured in the database, so body mass index (BMI; >27 
kgim2) was explored as a surrogate fifth measure. Angiographic assessment was 
